• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Emotional Changes (1831); Fatigue (1849); Unspecified Infection (1930); Menstrual Irregularities (1959); Pain (1994); Urinary Tract Infection (2120); Abnormal Vaginal Discharge (2123); Vertigo (2134); Weight Changes (2607); Heavier Menses (2666)
Event Type  Injury  
Event Description
This spontaneous case was reported by a lawyer and describes the occurrence of pelvic pain ('pain ¿ pelvic/abdominal') in a female patient who had essure inserted for female sterilisation and female sterilization.The occurrence of additional non-serious events is detailed below.On (b)(6) 2013, the patient had essure inserted.On an unknown date, the patient experienced pelvic pain (seriousness criteria medically significant and intervention required), abdominal pain ("pain ¿ pelvic/abdominal"), dysmenorrhoea ("dysmennorhea (cramping)"), menorrhagia ("bleeding ¿ menorrhagia (heavy menstrual bleeding)"), vertigo ("type of autoimmune diagnosed ¿ vertigo"), psychological trauma ("psych injury related to essure? yes"), bladder disorder ("bladder/urinary problems ¿ bladder probs"), urinary tract infection ("uti"), fatigue ("fatigue"), cystitis ("bladder infection") and vaginal discharge ("vaginal discharge") and was found to have weight increased ("weight gain").The patient was treated with surgery (partial hystterectomy , bilateral salpingectomy).Essure was removed on (b)(6) 2017.At the time of the report, the pelvic pain, dysmenorrhoea, vertigo, psychological trauma, bladder disorder, urinary tract infection, fatigue, weight increased, cystitis and vaginal discharge outcome was unknown and the menorrhagia had resolved.The reporter considered abdominal pain, bladder disorder, cystitis, dysmenorrhoea, fatigue, menorrhagia, pelvic pain, psychological trauma, urinary tract infection, vaginal discharge, vertigo and weight increased to be related to essure.The reporter commented: discrepancy noted in insertion date- (b)(6) 2013, (b)(6) 2013.The patient received treatment for menorrhagia, psychological trauma, fatigue, weight increased.Diagnostic results (normal ranges are provided in parenthesis if available): imaging procedure - on (b)(6) 2013: bilateral occlusion.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 30-aug-2019: plaintiff fact sheet received : incident category updated.Event ¿ injury¿ was replaced with events given in the sd.Events added- pelvic pain, abdominal pain, dysmenorrhoea, menorrhagia, vertigo, psychological trauma, bladder disorder, urinary tract infection, fatigue, weight increased, cystitis, vaginal discharge.Outcome of event menorrhagia taken as ¿recovered / resolved¿.Removal date added.Insertion date updated.Reporter information, patient details , product indication updated.Lab data added.Incident no lot number or device sample was received in this case.At this time, we have no information suggesting that the device failed to meet its specifications.We will conduct a review of our complaint records information become available from our investigation, this will be and other non-conformances data; should any new and reportable provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k shaw lamberson
100 bayer blvd, p.o. box 915
whippany, NJ 07981
MDR Report Key9002146
MDR Text Key162052004
Report Number2951250-2019-06192
Device Sequence Number1
Product Code HHS
UDI-Device Identifier10888853003051
UDI-Public(01)10888853003051
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Reporter Occupation Other
Type of Report Initial
Report Date 09/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/12/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Was Device Available for Evaluation? No
Date Manufacturer Received08/30/2019
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-